Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|April 11, 2022
Screening of σ<sub>2</sub> Receptor Ligands and <i>In Vivo</i> Evaluation of <sup>11</sup>C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a σ<sub>2</sub> Receptor Brain PET TracerHo Young Kim, Ji Youn Lee, Chia-Ju Hsieh, et al.
Scientific Reports|November 24, 2021
Reconciling biome-wide conservation of an apex carnivore with land-use economics in the increasingly threatened Pantanal wetlandsFernando R Tortato, Rafael Hoogesteijn, Allison L Devlin, et al.
Oncogene|April 17, 1997
Frequent inactivation of p16INK4a in oral premalignant lesionsV Papadimitrakopoulou, J Izzo, S M Lippman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 7, 2019
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's diseaseMichael Grundman, Roger Morgan, Jason D Lickliter, et al.
Plos One|June 12, 2014
Individual-based ant-plant networks: diurnal-nocturnal structure and species-area relationshipWesley Dáttilo, Roberth Fagundes, Carlos A Q Gurka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer developmentV A Papadimitrakopoulou, J Izzo, L Mao, et al.
Eneuro|October 8, 2020
Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and DiseaseNicholas J Izzo, Martí Colom-Cadena, Aladdin A Riad, et al.
ACS Medicinal Chemistry Letters|September 17, 2021
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's DiseaseGilbert M Rishton, Gary C Look, Zhi-Jie Ni, et al.
Analytical Biochemistry|April 25, 2003
Determination of endogenous extracellular signal-regulated protein kinase by microchip capillary electrophoresisDustin E Starkey, Yasser Abdelaziez, Chong H Ahn, et al.
Alzheimer'S Research & Therapy|March 4, 2020
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's diseaseMartí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, et al.
Pageof 7